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address the functional activity of proteases, two papersCatching Proteases in Action
in this issue from Harris, et al. and Winssinger, et al.with Microarrays describe microarray technologies to identify proteases
and their substrates from complex mixtures with pep-
tide-nucleic acid (PNA)-encoded libraries of activity-
based probes [1] and fluorogenic peptide substrates [2],
Proteases regulate many essential functions in biol- respectively (Figure 1).
ogy, yet their precise roles are only beginning to be By and large, the characterization of protease sub-
unraveled. In this issue, two related papers describe strates has been determined with purified proteins or
a novel method to dissect specific protease activities peptide libraries in vitro, which then suggests potential
from complex mixtures [1, 2]. substrates in vivo. The development of positional-scan-
ning fluorogenic-substrate libraries has allowed the
characterization of preferred amino acids at the site ofProteolysis provides an irreversible means to activate
proteolysis and has been used to determine the substrateor terminate signaling events in complex biological set-
specificities for several protease families in a high-through-tings by destruction of proteins. With greater than 500
put manner [7–9]. Using these positional-scanning sub-putative protease genes in the typical mammalian ge-
strate libraries, Harris, et al. evaluated the proteolytic activ-nome, understanding their precise roles in biology is
ities in dust mite extracts that may be responsible fordaunting [3]. The generation of protease-deficient mice
allergies [1]. By including class-specific protease inhibi-and small-molecule inhibitors has revealed essential
tors, they showed that the predominant proteolytic ac-functions for proteases in many areas of biology, ranging
tivities in dust mite extracts that cleaved P1 basic resi-from cell cycle control [4] to antigen presentation [5]
dues were attributed to cysteine proteases, whereasand extracellular matrix remodeling [6]. Functional re-
serine proteases were responsible for cleaving sub-dundancy within protease subfamilies and limited meth-
strates with P1 proline residues. Although these posi-ods for identifying substrates in vivo complicate analy-
tional-scanning peptide libraries revealed the overallsis. The majority of proteases are synthesized as
proteolytic activities in dust mite extracts, the specificzymogens and are activated only in specific subcellular
protease(s) responsible for these activities from com-compartments or upon stimulation. Furthermore, many
plex mixtures remained to be identified.proteases have endogenous inhibitors that attenuate
In order to retrieve the cysteine-protease(s) from thetheir destructive capacity. As proteolysis is regulated
dust mite extracts, Harris et al. turned to mechanism-posttranslationally, the evaluation of mRNA or polypep-
tide levels do not necessarily reflect their activity. To based probes that irreversibly label active enzymes [1].
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Figure 1. Characterization of Protease Activ-
ities from Complex Mixtures with PNA-
Encoded Libraries of Activity-Based Probes
and Fluorogenic Substrates
After the reaction of purified protease(s) or
cell lysates with PNA-encoded libraries, the
identity of an activity-based probe or a pep-
tide substrate is revealed upon hybridization
with oligonucleotide microarrays. The PNA-
encoded libraries enable irreversible inhibi-
tors and peptide substrates to be rapidly
identified, which facilitates the development
of small molecule inhibitors for in vivo appli-
cations.
Activity-based probes appended with visualization or throughput analysis of protease substrate specificity,
the immobilization of substrates on a solid support canaffinity tags (I125, fluorescent dyes, azides, biotin, or hap-
tens) have been developed for several enzyme families affect the interaction of substrates with enzymes. By
using PNA-encoded libraries, Winssinger, et al. allowedand are powerful tools to measure functional enzymes
in complex mixtures [10]. Thus, dust mite extracts were the hydrolysis of fluorogenic peptides to occur in solu-
tion, which upon hybridization with oligonucleotidereacted with a library of PNA-encoded peptide acrylate
inhibitors to selectively label cysteine-proteases in solu- arrays, reveals the identity of the cleaved peptides [2].
Importantly, Winssinger, et al. demonstrate that the at-tion. After removal of unreacted PNA-encoded peptide
acrylates, PNA-labeled cysteine-proteases were hybrid- tachment of PNA to fluorogenic peptides does not signif-
icantly interfere with substrate hydrolysis when comparedized onto DNA-microarrays to identify reactive peptide
acrylates, an elegant approach that was previously es- with unmodified fluorogenic peptides. From a practical
point of view, the fluorescent emission of rhodamine istablished by the same authors [11]. The most potent
PNA-encoded inhibitor was then synthesized as a biotin- relatively insensitive to changes in pH and enables the
microarray analysis to be performed with standard in-ylated derivative and used to retrieve the targeted prote-
ase(s) after enrichment with streptavidin beads. Mass strumentation. Experiments with individual PNA-encoded
rhodamine-peptide substrates and purified proteasesspectrometry and SDS-PAGE analysis showed that Der
p 1 and Der p 10 are the cysteine-proteases labeled by established good specificity and sensitivity (100 pmol)
for the method. Moreover, these PNA-encoded fluoro-the most potent peptide acrylate inhibitor, with Der p 1
being the major target. It has been proposed that cleav- genic peptide libraries can also be applied to complex
mixtures of proteases from cell lysates or extracts,age of CD25 (interleukin-2 receptor  chain) on regula-
tory T cells by Der p 1 induces allergies. Indeed, treat- which reveal differences in protease profiles when com-
paring nonapoptotic and apoptotic cells as well as clini-ment of dust mite extracts with the Der p 1 inhibitor
blocked cleavage of CD25 in a dose-dependent manner. cal blood samples.
It is clear that many biological processes are regulatedThis activity-based profiling approach, in combination
with PNA-encoded libraries, illustrates how specific pro- posttranslationally, and proteolysis is a prime example.
Therefore, new approaches that can detect how suchteases from complex mixtures could be identified for a
phenotype of interest and provides a powerful method activities are modulated in a high-throughput fashion are
essential for functional proteomics. The development offor functional proteomic studies.
In the accompanying paper, Winssinger, et al. demon- PNA-encoded libraries provides a powerful method for
profiling the activity of proteases and recovering themstrate that the PNA-encoding strategy can also be ap-
plied to fluorogenic peptide libraries [2]. The mixture from complex mixtures [1, 2]. The ability to perform
reactions with PNA-encoded libraries in solution is key,of fluorogenic peptides in positional-scanning libraries
precludes the identification of a precise peptide sub- which avoids artifacts with immobilized inhibitors/sub-
strates, on the likely assumption that PNA tags them-strate for the protease of interest and only suggests the
preferred amino acids at each position of the peptide selves do not interfere with enzyme activity. In addition,
the use of microarray technology enables the miniatur-substrate. To resolve this issue, fluorogenic peptide mi-
croarrays were printed on glass slides for spatial separa- ization of protease assays for high-throughput analysis
and will be particularly useful for clinical samples whention of individual substrates [12]. While these peptide
microarrays have good reactivity and enable high- limited amounts of material are available. The informa-
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Thus, many of the former problematic issues affectingA Suppression Strategy for
target-based screening are circumvented.Antibiotic Discovery For example, by using a phenotype-based screen,
Mitchison, Schreiber, and colleagues [2] identified an
inhibitor of mitosis in mammalian cells with monopolar
spindles, out of a library of 16,320 compounds. TheHigh-throughput phenotype screening and target
inhibitor discovered, monastrol, attacks the motility ofidentification have been combined in an effort to iso-
the mitotic kinesin Eg5, preventing normal spindle bipo-late antimicrobial, small-molecule therapeutics [1].
larity and thereby validating it as a potential anticancerThis approach, developed by Brown and colleagues
drug. At the time of this study, the only other previouslyand reported in this issue, is a major technological
known inhibitors of kinesin were cell impermeable. Thisadvance for antimicrobial drug discovery.
work clearly demonstrates the advantages of employing
phenotype screens in finding compounds that haveThe discovery and development of novel antimicrobials
novel activities within a biological system.via target-based approaches has historically been
However, there is a slight problem. Although pheno-plagued by difficulties associated with optimizing small
type screens allow the rapid and selective identificationmolecule leads out of biochemical screens while pre-
of compounds that elicit a specific biological response,serving or improving upon antimicrobial activity. This is
the mode of action of active compounds cannot bedue in large part because the factors governing small-
effectively and clearly deduced given the inherent com-molecule permeability and substrate selection criteria
plexity resulting from the large number of possible tar-for efflux pumps in bacterial cells are poorly understood
gets whose function is altered by the presence of thephenomena. However, high-throughput, phenotype-
biological modifier. The success rate of finding a specificbased screening methods offer a new promising strat-
mechanism of action hinges on the stringency affordedegy for identifying compounds from high-throughput
by the phenotype screen as well as the level of knowl-screens that elicit a specific biological response. Unlike
edge of the possible targets impacted by the small-target-based screening of biochemical activities, phe-
molecule effector. In the aforementioned example, Mit-notype-based screening selects for compound candi-
chison and Schreiber’s search for a target was facilitateddates that can penetrate cells, remain relatively unaf-
fected by efflux pumps, and function properly in vivo. by the fact that the small molecule caused a mitotic
